MedTrace Logo

Clinical Investigation of Omega Refractive Capsule Model V With Use of an FDA Approved IOL

NCT04574102 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2022-04-20

No results posted yet for this study

Summary

The objective of this study is to evaluate the safety and effectiveness of the

investigational Omega Refractive Capsule (model V)

Conditions

  • Cataract

Interventions

DEVICE

Omega Refractive Capsule with FDA approved Intraocular Lens

Omega Refractive Capsule with FDA approved Intraocular Lens

DEVICE

FDA approved Intraocular lens

FDA approved Intraocular lens

Sponsors & Collaborators

  • Omega Ophthalmics

    lead INDUSTRY

Principal Investigators

  • Claudio Orlich, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-09
Primary Completion
2021-06-09
Completion
2021-11-15

Countries

  • Costa Rica

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04574102 on ClinicalTrials.gov